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Guldemeester, Alexandra, Kurt R. Stenmark, George
H. Brough, and Troy Stevens. Mechanisms regulating
cAMP-mediated growth of bovine neonatal pulmonary artery
smooth muscle cells. Am. J. Physiol. 276 (Lung Cell. Mol.
Physiol. 20): L1010–L1017, 1999.—Neonatal pulmonary ar-
tery smooth muscle cells (PASMCs) exhibit enhanced growth
capacity and increased growth responses to mitogenic stimuli
compared with adult PASMCs. Because intracellular signals
mediating enhanced growth responses in neonatal PASMCs
are incompletely understood, we questioned whether 1) Gq
agonists increase cAMP content and 2) increased cAMP is
proproliferative. Endothelin-1 and angiotensin II increased
both cAMP content and proliferation in neonatal but not in
adult PASMCs. Inhibition of protein kinase C and protein
kinase A activity nearly eliminated the endothelin-1- and
angiotensin II-induced growth of neonatal PASMCs. More-
over, cAMP increased proliferation in neonatal but not in
adult cells. Protein kinase C-stimulated adenylyl cyclase was
expressed in both cell types, suggesting that insensitivity to
stimulation of cAMP in adult cells was not due to decreased
enzyme expression. Our data collectively indicate that pro-
tein kinase C stimulation of cAMP is a critical signal mediat-
ing proliferation of neonatal PASMCs that is absent in adult
PASMCs and therefore may contribute to the unique propro-
liferative phenotype of these neonatal cells.
adenosine 38,58-cyclic monophosphate; lung; development;
endothelin-1; angiotensin II; signal transduction
ADAPTATION OF THE PULMONARY CIRCULATION to postnatal
life is a process that requires both growth and differen-
tiation of vascular wall cells. In smooth muscle cells
(SMCs), there is a transition from a fetal to a more
adultlike phenotype (27). Several studies (15, 26) have
demonstrated that when the normal transition to post-
natal life is interrupted by hypoxia or increased pulmo-
nary blood flow, marked proliferative changes in pulmo-
nary artery (PA) SMCs (PASMCs) are observed that
exceed those observed when adult animals are exposed
to these stimuli. Similarly, SMCs derived from neona-
tal pulmonary arteries are less differentiated and ex-
hibit enhanced growth responses to mitogenic stimuli
compared with the relatively differentiated and quies-
cent SMCs derived from the adult pulmonary artery (6,
30). Thus the increased growth capacity of neonatal
PASMCs likely contributes to both normal pulmonary
vascular development and the predisposition to develop
exorbitant pulmonary vascular remodeling in response
to injury in the neonatal period.
Although it is generally accepted that neonatal
PASMCs possess increased growth responses to mito-
genic stimuli, the unique intracellular signaling mecha-
nism(s) that account for the enhanced growth respon-
siveness are incompletely understood. Ligands such as
insulin-like growth factor-I and platelet-derived growth
factor are coupled to tyrosine kinase signal transduc-
tion pathways that activate extracellular signal-
regulated kinases (ERKs) and potently increase PASMC
growth (2). Dempsey and colleagues (6, 8) demon-
strated that receptor tyrosine kinase-dependent ago-
nists induced fourfold greater increases in neonatal
than in adult PASMC growth, suggesting that ERK-
dependent proliferation is developmentally controlled.
It has additionally been shown that constitutive and
phorbol 12-myristate 13-acetate-sensitive protein ki-
nase (PK) C activity is increased in neonatal compared
with adult PASMCs and that increased PKC activity
promotes neonatal PASMC growth and also synergisti-
cally promotes ERK-dependent PASMC proliferation
(6, 7). However, how PKC synergistically interacts with
ERK to enhance neonatal PASMC growth and what
accounts for enhanced PKC-dependent proliferation in
neonatal compared with adult SMCs is not clear at the
present time.
Emerging data indicate that in some cell systems
PKC may synergistically promote ERK-dependent pro-
liferation by elevating cAMP. Faure and colleagues (11,
12) demonstrated that either Gq or Gqa activation of
PKC or direct activation of PKC with phorbol esters
stimulated ERK activity, and, similarly, activation of Gs
or direct activation of adenylyl cyclase elevated cAMP
and stimulated ERK activity. Although these data
implicate either Gq- or Gs-coupled mechanisms in regu-
lation of ERK activity, they do not clearly demonstrate
how Gq-coupled agonists may elevate cAMP. However,
recent elucidation of the molecular complexity of ad-
enylyl cyclases revealed type II adenylyl cyclase is
activated by PKC (32). These data suggest the possibil-
ity that a linkage between PKC and ERK activation is
PKC stimulation of type II adenylyl cyclase and eleva-
tion of cAMP. Thus, as suggested by Faure and col-
leagues (11, 12), Gq-coupled signal transduction path-
ways activate PKC, which may promote adenylyl cyclase
II synthesis of cAMP that, in turn, regulates ERK. It is
equally clear that cAMP can have opposite effects on
ERK activity in other cell systems (11). Thus second
messenger regulation of ERK and proliferation may be
unique in phenotypically distinct cell types.
Because neonatal SMCs demonstrate unique PKC-
associated growth properties, it is possible that PKC
regulation of cAMP may play an important role in the
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increased growth responses in neonatal compared with
adult PASMCs. Therefore, the goal of the present study
was to test the hypothesis that Gq-coupled agonists
promote PKC-dependent stimulation of cAMP in neona-
tal PASMCs and that such elevation of cAMP would be
proproliferative. To test our hypothesis, we utilized two
endogenous polypeptides, endothelin (ET)-1 and angio-
tensin II (ANG II), widely recognized as Gq-coupled
PKC agonists that control SMC growth and differentia-
tion (1, 9, 10, 13, 14, 16, 24, 25, 27). Both cAMP
responses and indexes of proliferation were measured
in neonatal and adult PASMCs.
METHODS
Isolation and culture of neonatal and adult PASMCs. SMCs
were obtained from the main PAs of neonatal (14-day-old)
calves and adult (2-yr-old) cows. Neonatal and adult PASMCs
were considered matched because they were derived from the
middle media at the same vascular site with previously
described techniques (6–8). Briefly, main PAs were dissected
from calves and cows immediately after death and trans-
ported to the laboratory immersed in MEM (pH 7.4) contain-
ing 200 U/ml of penicillin, 0.2 mg/ml of streptomycin, and 5
mg/ml of amphotericin B at 25°C. The PAs were opened, and
the endothelium was scraped off. Explants of smooth muscle
tissue (2 3 3 mm) were dissected from the middle media of PA
strips. They were plated in petri dishes containing MEM with
10% serum, 100 U/ml of penicillin, and 0.1 mg/ml of strepto-
mycin. The PASMCs at confluence exhibited characteristic
‘‘hill-and-valley’’ (adult) and ‘‘swirllike’’ (neonatal) morpholo-
gies by phase-contrast microscopy and stained in a homoge-
neous fibrillar pattern with smooth muscle-specific monoclo-
nal anti-a-smooth muscle actin antibody (Sigma, St. Louis,
MO) (6–8). Cell cultures were maintained in MEM (pH 7.4)
containing 1% L-glutamine, 200 U/ml of penicillin, 0.2 mg/ml
of streptomycin, and 0.5% MEM-nonessential amino acid
solution (all from Sigma) with 10% bovine calf serum (BCS;
Hyclone Laboratories, Logan, UT) and incubated in a humidi-
fied atmosphere with 5% CO2 at 37°C. The medium was
changed biweekly. To ensure that any differences seen be-
tween the cell populations were due to intrinsic differences
and not induced in vitro, we controlled identical sites of
harvest, time in culture, passage number, and growth condi-
tions of the neonatal and adult PASMCs. The cells were
studied between primary culture and third passage. Cells
were grown to confluence in T75 flasks in the presence of 10%
BCS, removed from the tissue culture flasks by trypsinization
(0.2 g/l of trypsin-0.5 g/l of EDTA; Sigma), and then seeded at
equal density into 24-well tissue culture plates (50 3 103
cells/well). Cells were grown to confluence in the presence of
10% serum in 2–3 days and incubated for 72 h in serum-
deprived medium (0.1% BCS) to achieve a quiescent state.
Measurement of [3H]thymidine incorporation into DNA.
DNA synthesis was measured as previously described (6–8).
For these experiments, neonatal and adult PASMCs were
grown to confluence, and a quiescent state was achieved after
72 h in 0.1% BCS-MEM. [3H]thymidine (0.5 µCi/well; ICN
Biochemicals, Irvine, CA) was added together with ET-1,
ANG II, forskolin, or 8-bromo-cAMP (Sigma) for 24 h. In
studies of [3H]thymidine incorporation during PKC or cAMP
blockade, the cells were pretreated with the specific PKC
inhibitors chelerythrine chloride and Ro 31-8220 or the cAMP
antagonist Rp diasteromer of adenosine 38,58-cyclic monophos-
phothioate (Rp-cAMPS; all Alexis, San Diego, CA) for 15 min,
followed by application of [3H]thymidine (0.5 µCi/well) to-
gether with ET-1, ANG II, forskolin, or 8-bromo-cAMP for 24
h. Cell counts were obtained at the end of the incubation with
a hemocytometer.After the cells were washed with phosphate-
buffered saline (PBS) and 0.2 M perchloric acid (0.5 ml/well)
was added for 2–3 min, the cells were again washed with PBS
(1 ml/well), and then 1.0% SDS-0.01 N NaOH (0.3 ml/well)
was added. The contents of each well were added to 4 ml of
Ecoscint H scintillation cocktail (National Diagnostics, At-
lanta, GA), and the radioactivity was measured with a
Beckman LS 7500 beta-scintillation counter (Irvine, CA).
Incorporation of [3H]thymidine into DNA is expressed as
counts per minute (cpm) per cell.
Measurement of change in cell number. Cells were trypsin-
ized for 10 min, gently triturated four times after the addition
of an equal volume of MEM-10% serum, and counted with a
standard hemocytometer.
Measurement of cAMP accumulation. cAMP measure-
ments were made with confluent, quiescent neonatal and
adult PASMCs grown to confluence in 24-well plates (plated
at 50 3 103 cells/well) with a standard radioimmunoassay
(Biomedical Technologies, Stoughton, MA). Studies were con-
ducted with MEM at pH 7.35–7.45. In studies of cAMP
accumulation, either vehicle control, ET-1, or ANG II was
added to the cells, and the cells were incubated at 37°C for 90
min. In selected experiments, the cAMP signal was amplified
with the a-adrenergic agonist isoproterenol (Sigma) along
with the vehicle control, ET-1, or ANG II. In all studies, the
solutions contained the phosphodiesterase inhibitor 3-isobutyl-
1-methylxanthine (IBMX; Sigma) to inhibit cAMP break-
down. In studies of cAMP accumulation during PKC block-
ade, the cells were pretreated with the specific PKC inhibitors
chelerythrine chloride or Ro 31-8220 for 15 min, followed by
application of the vehicle control, ET-1, or ANG II. After
incubation, the cells were washed with PBS, and the reac-
tions were stopped with 1 M NaOH and then neutralized to
pH < 7.0 with 1 M HCl. The solutions were acetylated, the
tubes were centrifuged, and the supernatant was decanted.
Radioactivity of the precipitate was counted, and sample
cAMP was calculated from a standard curve. cAMP was
standardized to cell counts obtained from untreated wells at
the end of the incubation.
RT-PCR detection of adenylyl cyclase. Expression of PKC-
stimulated adenylyl cyclase (type II) was tested generally as
previously described (4). Briefly, total RNA was extracted
from cell monolayers with Qiagen RNeasy (Qiagen, Santa
Clarita, CA) and subjected to first-strand synthesis with
reverse transcriptase (GIBCO BRL) and oligo(dT) primer
after treatment of RNA with DNase I (GIBCO BRL). Degener-
ate primers directed to the highly conserved C2A region of
adenylyl cyclase were used for PCR amplification (28). PCR
products were ligated into a cloning vector (TOPO TA cloning
kit, Invitrogen, San Diego, CA) and transformed into compe-
tent cells. After PCR screening of clones for proper inserts,
bacterial cultures were made and grown for 16–18 h. Plas-
mids were purified by QIAprep Spin Plasmid kit (Qiagen).
Sequencing was performed by automated fluorescence se-
quencing (ABI370A DNA Sequencer).
Lung fixation. Neonatal calves were killed by an intrave-
nous overdose of barbiturate and exanguinated before re-
moval of the lungs. The superior lobe of the left lung was fixed
in Formalin and cut, and lung blocks were embedded in
paraffin. Sections of paraffin-embedded tissue were cut with a
microtome at 4 µm. Before the slides were stained, the
paraffin was removed from the slides with xylene, and the
tissue was rehydraded in a graded alcohol series.
Immunohistochemistry. Immunostaining was generally as
previously described (4, 17). To test for adenylyl cyclase
expression, the slides were incubated in 0.3% H2O2 in metha-
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nol for 30 min to decrease endogenous peroxidase activity.
The slides were incubated with blocking solution (1% BSA
and 0.05% Triton X-100 in PBS) to reduce nonspecific binding
of antibodies. Primary antibodies (Santa Cruz Biotechnology,
Santa Cruz, CA) for type II adenylyl cyclase were diluted
1:250 in PBS with 0.1% BSA and 0.05% Triton X-100 and
incubated overnight at room temperature. After the slides
were washed, biotinylated goat anti-rabbit IgG antibody
diluted 1:250 in PBS with 0.05% Tween was added for 2 h.
The slides were washed and incubated in an avidin-biotin-
horseradish peroxidase complex (Vectastain ABC Kit, Vector
Laboratories, Burlingame, CA) diluted 1:250 in PBS with
0.05% Tween for 1.5 h. The slides were again washed and
developed in 5 mg of diaminobenzidine, 10 ml of 50 mM Tris,
pH 7.4, and 10 µl of 30% H2O2 for 1 min, rinsed with tap
water, and counterstained briefly with hematoxylin before
dehydration and mounting. In control experiments, blocking
peptide (Santa Cruz Biotechnology) was diluted 1:250 and
coincubated with the type II adenylyl cyclase polyclonal
antibody.
The antibody for type II adenylyl cyclase was generated
against the sequence KTYFVNTEMSRSLSQSNVAS of the
type II enzyme. Specificity of the antibody for type II adenylyl
cyclase has been confirmed by Santa Cruz Biotechnology with
Western blotting and immunocytochemistry.
Statistical analysis. Data are reported as means 6 SE.
One-way ANOVA with multiple comparisons was used to
compare means between groups. A P value , 0.05 was used to
indicate significance.
RESULTS
Stimulation of cAMP. To address whether ET-1 and
ANG II could increase proliferation in neonatal PASMCs
through a cAMP-mediated pathway, we first measured
cAMP levels in PASMCs in the presence of the phospho-
diesterase inhibitor IBMX (500 µM) and in response to
ET-1 and ANG II. Baseline cAMP was higher in neona-
tal PASMCs than in adult cells (Fig. 1A). Both ET-1 (10
nM) and ANG II (10 nM) stimulated cAMP synthesis
(<12- and 4-fold, respectively; P , 0.05; n 5 6 cells) in
neonatal PASMCs over 90 min but did not change
cAMP levels in adult cells (Fig. 1A). Similar results
were observed in response to ET-1 and ANG II in the
presence of isoproterenol (25 µM) and IBMX over a
5-min time course (data not shown).
We investigated the possibility that ET-1 and ANG II
increased cAMP in neonatal PASMCs by PKC-medi-
ated stimulation of adenylyl cyclase. Pretreatment of
these cells with the PKC inhibitor chelerythrine (1 µM)
reduced baseline cAMP (30%) and eliminated ET-1 and
ANG II stimulation of cAMP (Fig. 1B). Similar results
were obtained with the specific PKC blocker Ro 31-8220
(5 µM; data not shown). These data are consistent with
the idea that basal cAMP levels and elevation of cAMP
after application of ET-1 and ANG II are regulated
through PKC stimulation of adenylyl cyclase.
Expression of type II (PKC-stimulated) adenylyl cy-
clase in vitro and in vivo. The activity of type II
adenylyl cyclase is stimulated by PKC (32). We next
sought to identify whether the type II enzyme is
expressed in neonatal PASMCs using RT-PCR cloning.
Sequence analysis of a 261-nucleotide product revealed
94 and 90% homology between the bovine product and
the respective human and rat species at the nucleotide
level. Deduced amino acid alignments demonstrated 97
and 95% homology between the presently cloned bovine
and respective human and rat sequences (Table 1).
Although type II adenylyl cyclase is expressed in
cells in culture, isolation and culture per se may induce
phenotypic changes in the population of PASMCs. Thus
we determined whether PKC-stimulated adenylyl cy-
clase was evident in neonatal and adult PASMCs in
vivo using established immunohistochemical tech-
niques. A recently developed adenylyl cyclase type
II-specific polyclonal antibody was utilized. We found
expression of type II adenylyl cyclase throughout the
pulmonary vasculature. Especially important is detec-
tion of the type II PKC-stimulated adenylyl cyclase in
the medial layer at the site where excessive prolifera-
tion of PASMCs in response to mitogenic stimuli occurs
(Fig. 2). Immunoreactivity was eliminated by coincuba-
tion of the PKC-stimulated adenylyl cyclase type II
antibody with a blocking peptide, suggesting antibody
specificity to type II adenylyl cyclase.
SMC proliferation. To assess the contribution of
cAMP to growth in neonatal and adult PASMCs, we
measured the effects of the direct adenylyl cyclase
agonist forskolin (10 µM) and the cAMP analog 8-bromo-
cAMP (1 µM) on [3H]thymidine incorporation. Basal
Fig. 1. Endothelin (ET)-1 and ANG II activate protein kinase (PK) C
and increase cAMP in neonatal pulmonary artery (PA) smooth
muscle cells (SMCs). Cells were plated at 50,000 cells/well and
studied in a confluent and quiescent state. After application of vehicle
or treatment conditions, cAMP was measured with radioimmunoas-
say and standardized to cell counts. Values are means 6 SE. A:
baseline cAMP in presence of IBMX was higher in neonatal than in
adult PASMCs. ET-1 (10 nM) and ANG II (10 nM) increased baseline
cAMP over a 90-min time course in neonatal but not in adult cells
(n 5 6/group). Significantly different (P , 0.05) from: *control
PASMCs; **neonatal PASMCs. B: pretreatment with (1) chelery-
thrine (1 µM) reduced baseline cAMP and eliminated ET-1- and ANG
II-induced rise in cAMP in neonatal PASMCs (n 5 6/group). 2,
Without. *Significantly different from without chelerythrine, P , 0.05.
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[3H]thymidine incorporation was threefold higher in
neonatal than in adult cells. Forskolin (10 µM) and
8-bromo-cAMP (1 µM) induced a twofold increase in
[3H]thymidine incorporation in neonatal PASMCs but
did not affect [3H]thymidine incorporation in adult
PASMCs (P , 0.05; n 5 4 cells; Fig. 3). Cell counts after
forskolin and 8-bromo-cAMP application were higher in
neonatal but not in adult PASMCs (data not shown),
consistent with a proproliferative effect of cAMP in
these neonatal cells (30).
Our next studies investigated whether neonatal
PASMCs exhibit greater growth responses than adult
cells to the Gqa agonists ET-1 (10 nM) and ANG II (10
nM). ET-1 and ANG II increased [3H]thymidine incorpo-
ration three- and twofold, respectively, in neonatal
PASMCs but did not increase [3H]thymidine incorpora-
tion in adult PASMCs (P , 0.05; n 5 4 cells; Fig. 4). Cell
counts after ET-1 and ANG II application were also
higher in neonatal but not in adult PASMCs (data not
shown).
We investigated the role of PKC in the proliferative
response to ET-1 and ANG II in neonatal PASMCs
using chelerythrine. Figure 4B shows that PKC inhibi-
tion attenuated the basal and ET-1- and ANG II-
mediated increase in [3H]thymidine incorporation (6,
75, and 75%, respectively; P , 0.05; n 5 4 cells).
Identical results were achieved with the PKC blocker
Ro 31-8220 (5 µM; data not shown). A previous report
from our laboratory (30) has shown that PKC inhibitors
at concentrations presently reported do not cause sig-
nificant cell death, confirming that inhibition of PKC
decreased proliferation rather than induced apoptosis
or necrosis. We next tested the role of adenylyl cyclase
and cAMP in increased proliferation by blocking cAMP-
dependent protein kinase activity with Rp-cAMPS (1
mM). Rp-cAMPS attenuated basal and ET-1- and ANG
II-mediated increases in [3H]thymidine incorporation
(6, 85, and 78%, respectively; P , 0.05; n 5 4 cells; Fig.
5), confirming a proproliferative action of cAMP in
neonatal PASMCs. Altogether, these data suggest that
stimulation of proliferation in quiescent neonatal
PASMCs is at least partly regulated through PKC
stimulation of adenylyl cyclase and cAMP.
DISCUSSION
Vascular SMCs derived from neonatal PAs exhibit
enhanced growth capacities to growth-promoting stimuli
compared with SMCs derived from adult pulmonary
arteries (6, 30). The reason for this unique phenomenon
is unclear, although enhanced growth capacity may
contribute to normal adaptive mechanisms after birth
as well as the need for continued pulmonary vascular
growth. Recent evidence (2, 6–8) indicated that com-
pared with adult PASMCs, neonatal PASMCs exhibit
enhanced growth responses to activation of ERK and
PKC. Moreover, stimulation of ERK occurred after
elevation of cAMP, suggesting that PKC stimulation of
cAMP may be a critical link to ERK-dependent prolifera-
tion (2, 6, 8, 11, 12, 22). However, it was unclear
whether activation of PKC influences PASMC cAMP
content and whether cAMP is proproliferative in
PASMCs. Novel findings from our study are that 1) Gq
agonists ET-1 and ANG II elevate neonatal but not
adult PASMC cAMP, 2) both neonatal and adult
PASMCs express a PKC-stimulated adenylyl cyclase,
and 3) ET-1, ANG II, and direct elevation of cAMP is
proproliferative in neonatal but not in adult PASMCs.
These data suggest that PKC stimulation of cAMP is a
critical signal mediating proliferation of neonatal
PASMCs that is absent in adult PASMCs and therefore
may contribute to the unique proproliferative pheno-
type of neonatal PASMCs.
Our initial studies sought to determine whether Gq
agonists ET-1 and ANG II promote cAMP synthesis.
Activation of PKC in diverse cell types, including
bronchial SMCs, increases cAMP content (22). Both
ET-1 and ANG II increased cAMP content in PASMCs
over a 90-min time course, and inhibition of PKC
prevented the ET-1- and ANG II-induced rise in cAMP.
Interestingly, neither Gq agonist tested elevated cAMP
content in adult PASMCs. Thus these data are the first
to demonstrate that PKC stimulation of cAMP is devel-
opmentally controlled.
Table 1. Comparison of rat, human, and bovine amino
acid sequences of type II adenylyl cyclase
Type II Isoform Sequence
1 10
Rat KTIGSTYMAA
Human KTIGSTYMAA
Bovine KITGCTYMAA
11 20
Rat TGLSAIPSQE
Human TGLSAVPSQE
Bovine TGLSAVPSQE
21 30
Rat HSQEPERQYM
Human HSQEPERQYM
Bovine HAQEPERQYM
31 40
Rat HIGTMVEFAY
Human HIGTMVEFAF
Bovine HIGTMVEFAF
41 50
Rat ALVGKLDAIN
Human ALVGKLDAIN
Bovine ALVGKLDAIN
51 60
Rat KHSFNDFKLR
Human KHSFNDFKLR
Bovine KHSFNDFKLR
61 70
Rat VGINHGPVIA
Human VGINHGPVIA
Bovine VGINHGPVIA
71 80
Rat GVIGAQKPQY
Human GVIGAQKPQY
Bovine GVIGAHKPQY
81 87
Rat DIWGNTV
Human DIWGNTV
Bovine DIWGNTV
Sequences are within C2A region of 2nd cytosolic loop of adenylyl
cyclase. Nos. on top, amino acid no. Boldface type, nonhomologous
amino acids. Bovine sequence is 97 and 95% similar to human and rat
sequences, respectively, within this region.
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Recent elucidation of multiple adenylyl cyclase spe-
cies revealed that certain isoforms (e.g., type II) are
stimulated by PKC (32), providing a putative mecha-
nism through which PKC may increase cAMP content.
Our next studies therefore determined whether PKC-
stimulated adenylyl cyclase was selectively expressed
in neonatal PASMCs. We tested expression of the type
II isoform by RT-PCR cloning using sequence-specific
oligonucleotide primers. Sequence analysis revealed
that type II adenylyl cyclase is expressed in both
neonatal and adult PASMCs. To confirm that expres-
sion of this enzyme was not an artifact of cell culture
per se, immunostaining was performed on sections
from intact neonatal and adult bovine lungs. Positive
staining was observed in the medial layers of large and
small vessels from animals of both developmental
stages. Thus these data indicate that the expression of
type II adenylyl cyclase is not developmentally con-
trolled and does not account for the distinct ET-1 and
ANG II responses in neonatal versus adult PASMCs.
Although PKC-stimulated adenylyl cyclase is ex-
pressed in both neonatal and adult cells, our data
indicated that PKC only stimulated the type II enzyme
in neonatal PASMCs, supporting the idea that mecha-
nisms controlling adenylyl cyclase activation are devel-
opmentally regulated. Dempsey et al. (6) previously
Fig. 2. PKC-stimulated adenylyl cyclase (type II) is expressed in pulmonary arteries and arterioles of neonatal and
adult animals. Diaminobenzadine staining (brown) was used to determine expression of type II adenylyl cyclase in
intact pulmonary circulation. Antibody specificity was tested by blocking diaminobenzadine staining with peptide
inhibitors against primary antibody (A and C). Medial sections of small (B) and large (D) neonatal pulmonary
arteries stained positive with adenylyl cyclase type II-specific polyclonal antibody. Most SMCs in medial layer of
small and large pulmonary arteries stained brown (B and D, arrowheads), demonstrating expression of adenylyl
cyclase type II. Data with pulmonary vessels from adult animals are not shown. Hematoxylin was used to
counterstain cell nuclei (purple).
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demonstrated that relative to adult cells, neonatal
PASMCs exhibit increased PKC activity under basal
conditions and increased sensitivity to the direct PKC
activator phorbol 12-myristate 13-acetate. It is there-
fore reasonable that increased PKC activity in neonatal
PASMCs stimulates type II adenylyl cyclase, whereas
lower PKC activity in adult cells does not stimulate
type II adenylyl cyclase. Multiple isoforms of PKC are
present in neonatal PASMCs, but the a-isozyme has
been implicated in increased growth responses (30).
Interestingly, the a-isozyme of PKC activates type II
adenylyl cyclase in Sf9 cells (34). Future studies will be
required to directly test the nature of PKC stimulation
of adenylyl cyclase activity in neonatal PASMCs, e.g.,
which PKC isoforms account for increased whole cellu-
lar PKC activity and activation of type II adenylyl
cyclase.
Our next studies were designed to address whether a
link exists between PKC stimulation of cAMP and
neonatal PASMC proliferation by determining whether
1) elevated cAMP is proproliferative, 2) PKC activation
is proproliferative, and 3) PKC stimulation of prolifera-
tion depends on cAMP. The role of cAMP on SMC
proliferation is controversial. Previous reports sug-
gested that cAMP may have either a negative or
positive influence on proliferation (23), with the effect
of cAMP depending on cell type (23), state of cell
differentiation (3), and stage of cell cycle (21). Neonatal
and adult PASMCs were ‘‘growth arrested’’ to mimic the
in vivo environment. Although previous studies (6, 30)
showed that neonatal PASMCs exhibit enhanced growth
capabilities, our present studies demonstrated that
these cells also exhibit higher basal cAMP levels,
consistent with the possibility that cAMP may function
as a positive stimulus for proliferation. We found that
two agents that increase cAMP (8-bromo-cAMP and
forskolin) also stimulate [3H]thymidine incorporation
and cell proliferation in neonatal but not in adult
PASMCs. Furthermore, direct inhibition of the cAMP-
dependent PK lowered basal [3H]thymidine incorpora-
tion in neonatal PASMCs. These data suggest that
cAMP is proproliferative in neonatal PASMCs and that
the action of cAMP-induced growth is developmentally
regulated as recently suggested in Schwann cells (31).
We next evaluated the influence of PKC on growth in
neonatal PASMCs. PKC activity is increased in neona-
tal versus adult PASMCs, and ET-1 and ANG II acti-
vate PKC. Furthermore, activation of PKC is generally
found to stimulate proliferation (6, 16, 20, 25, 34). In
our present studies, inhibition of PKC with chelery-
thrine and Ro 31-8220 decreased basal and ET-1- and
ANG II-stimulated [3H]thymidine incorporation, sug-
Fig. 3. Elevated cAMP promotes growth in neonatal PASMCs. Cells
were plated at 50,000 cells/well and studied in a confluent and
quiescent state.After application of treatment conditions, incorporation of
[3H]thymidine into DNA was measured. cpm, Counts/min. Values are
means 6 SE; n 5 4 cells/group. Basal [3H]thymidine incorporation in
neonatal PASMC was threefold higher than in adult cells. Forskolin
(10 µM) and 8-bromo-cAMP (1 µM) increased [3H]thymidine incorpo-
ration after 24 h in neonatal but not in adult cells. Significantly
different (P , 0.05) from: *control PASMCs; **neonatal PASMCs.
Fig. 4. ET-1 and ANG II activate PKC and stimulate growth of
neonatal PASMCs. Cells were plated at 50,000 cells/well and studied
in a confluent and quiescent state. After application of treatment
conditions, incorporation of [3H]thymidine into DNA was measured.
Values are means 6 SE; n 5 4 cells/group. A: ET-1 (10 nM) and
ANG II (10 nM) increased [3H]thymidine incorporation after 24 h in
neonatal but not in adult cells. Significantly different (P , 0.05) from:
*control PASMCs; **neonatal PASMCs. B: pretreatment with chel-
erythrine (1 µM) inhibited ET-1- and ANG II-stimulated neonatal
PASMC proliferation. *Significantly different from without chelery-
thrine, P , 0.05.
Fig. 5. Inhibition of PKA prevents ET-1 and ANG II stimulation of
neonatal PASMC growth. After pretreatment with Rp diasteromer of
adenosine 38,58-cyclic monophosphothioate (Rp-cAMPS; 1 mM) and
application of ET-1 or ANG II, incorporation of [3H]thymidine into
DNA was measured. Values are means 6 SE; n 5 4 cells/group. PKA
blockade attenuated basal and ET-1- and ANG II-induced increase in
[3H]thymidine incorporation in neonatal PASMCs. *Significantly
different from neonatal PASMCs, P , 0.05.
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gesting that increased growth in neonatal PASMCs
depends at least partly on PKC activity. However, PKC
inhibitors did not influence proliferation in adult
PASMCs. Both ET-1 and ANG II are generally believed
to stimulate growth in adult SMCs derived from the
systemic circulation (1, 5, 10, 27). Indirect evidence for
the involvement of ET-1 and ANG II in medial thicken-
ing of pulmonary arteries has also been shown in adult
rats (18, 33), but the direct effects of the polypeptides on
PASMC proliferation are less clear. For example, ET-1
was previously reported (16) to increase growth in
adult swine PASMCs in the presence of 0.5% serum,
whereas in the present study, ET-1 and ANG II were
not proproliferative in adult bovine PASMCs in the
presence of 0.1% serum. The reason for this discrep-
ancy is unclear, although it is possible that these agents
act as comitogenic stimuli, requiring other growth
factors to stimulate proliferation. Independent support
for this idea comes from the work of Morrell and
Stenmark (19), who observed that ANG II stimulated
proliferation of adult rat PASMCs only when the cells
were primed by preincubation with 10% serum but not
under serum-deprived conditions (0.1%). Thus our data
are consistent with the idea that ET-1 and ANG II alone
are insufficient to promote proliferation in adult
PASMCs and suggest that PASMCs possess a develop-
mentally regulated sensitivity to these vasoconstrictors
(29).
Our final series of experiments tested whether inhibi-
tion of PKA blocks ET-1- and ANG-II-stimulated in-
crease in neonatal PASMC proliferation. Indeed, the
PKA inhibitor Rp-cAMPS prevented Gq activation from
stimulating neonatal PASMC proliferation but did not
affect proliferation of adult PASMCs. Our data there-
fore demonstrate that ET-1 and ANG-II stimulate
PKC-dependent production of cAMP that is proprolifera-
tive in neonatal PASMCs; inhibitors of either PKC or
PKA prevent this stimulation of proliferation.
In summary, ET-1 and ANG-II activation of Gq acti-
vates PKC, which increases cAMP and promotes prolif-
eration of neonatal PASMCs. In contrast, ET-1 and
ANG II activation of Gq neither increases cAMP nor
promotes proliferation of adult PASMCs. The explana-
tion for this apparent developmental distinction is not
yet fully determined but is not due to altered expres-
sion of PKC-stimulated (type II) adenylyl cyclase. Based
on earlier work from our laboratory (6, 8), a likely
explanation is that increased constitutive PKC activity
and enhanced PKC responsiveness to activation ac-
counts for PKC stimulation of cAMP in neonatal versus
adult PASMCs. Now that a key link between PKC and
cAMP production has been established in neonatal
PASMCs, future studies may address the regulation of
ERK-dependent proliferation by cAMP.
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